#флудилка Ну что Дамы и Господа. Похоже разворот на Американском рынке. 😁 Акции производителей лекарств пошли в вверх. 😂 Нефтяных компаний и даже доллар. 😭 $USDRUB Неужели новогоднее ралли. 😳 Шортисты крепитесь. 😭😂😂😂Маржин колы не минуемы. 😂😂😂 NanoVibronix, Inc. (NASDAQ: NAOV) announced that the FDA 510(k) cleared PainShield MD PLUS, its dual-actuator ultrasound pain therapy device. Shares closed up 144% at $0.63. CinCor Pharma, Inc (NASDAQ: CINC) announced that its Phase 2 HALO trial of baxdrostat to treat uncontrolled hypertension did not meet its primary endpoint in Intention to Treat (ITT) population. Shares closed down 47% at $14.11. Modular Medical, Inc. (NASDAQ: MODD) announced that it will delay its 510(k) submission for its insulin pump product after it identified particular materials in the pump device incompatible with the sterilization process. Modular now expects to make its submission in the second quarter of 2023. Shares closed down 5% at $3.11. Axsome Therapeutics, Inc. (NASDAQ: AXSM) announced that its Phase 3 ACCORD trial of AXS-05 to treat agitation in patients with Alzheimer’s disease, met the primary and key secondary endpoints. Shares closed up 32% at $74.74. The FDA granted Fast Track Designation (FTD) to Kintara Therapeutics, Inc’s (NASDAQ: KTRA) REM-001 therapy for the treatment of patients with cutaneous metastatic breast cancer (CMBC). The program was paused in October in order for the company to conserve cash. Shares closed up 18% at $4.36. Anavex Life Sciences Corp. (NASDAQ:AVXL) reported earnings today with a net loss for the quarter of $14.3 million, or $0.18 per share, compared to a net loss of $11.7 million, or $0.15 per share for the same period last year. Shares closed down 23% at $9.10. TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares traded lower today following an SEC filing that reported an offering of 12,500,000 shares of common stock on a firm commitment basis. Shares closed down 17% at $0.40. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) filed an amendment to an S-1 filing from October regarding an offering. This amendment noted that the previously announced offering will consist of ,349,206 shares of common stock, together with warrants to purchase 1,349,206 shares of stock at $6.30 per unit. Shares closed down 20% at $0.17. Alaunos Therapeutics, Inc. (NASDAQ: TCRT) announced a public offering of its common stock. Shares are currently trading down 16% at $0.74 during after hours.